Histotripsy: The Next Generation of High‐Intensity Focused Ultrasound for Focal Prostate Cancer Therapy

2019 ◽  
Vol 39 (6) ◽  
pp. 1057-1067 ◽  
Author(s):  
Theodore J. Dubinsky ◽  
Tanya D. Khokhlova ◽  
Vera Khokhlova ◽  
George R. Schade
Keyword(s):  
Prostate Cancer ◽  
Cancer Therapy ◽  
High Intensity ◽  
Focused Ultrasound ◽  
High Intensity Focused Ultrasound ◽  
Next Generation ◽  
Prostate Cancer Therapy

scholarly journals "Modern approaches for antiandrogen-resistant prostate cancer therapy

2021 ◽  
Vol 8 (1) ◽  
pp. 71-75
Author(s):  
Felix Voinea ◽  
Laura Mazilu ◽  
Ioan Micu ◽  
Adrian Suceveanu ◽  
Madalina Iliescu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Therapy ◽  
Focused Ultrasound ◽  
Checkpoint Inhibitors ◽  
Experimental Treatment ◽  
High Intensity Focused Ultrasound ◽  
Unhealthy Lifestyle ◽  
The Metabolic Syndrome ◽  
High Lipid ◽  
Prostate Cancer Therapy

Prostate cancer represents the leading malignant tumor in men over 50 years of age with 400,000 new cases being diagnosed yearly in Europe. Even if the incidence rate is higher than the mortality rate, still there is an increasing trend when speaking of its mortality. The increasing incidence of the metabolic syndrome, the unhealthy lifestyle, the high lipid and Calcium intake, the high spread of infections with Human Papilloma Virus, Human Herpes Virus, the excess of androgen consumption and the longer life expectancy, are few of the main causes of prostate cancer increasing incidence. The new systemic therapies such as immunotherapy with Checkpoint Inhibitors or Poly, ADP-Ribose Polymerase inhibitors and local experimental procedures addressing tumor destruction, such as High- Intensity Focused Ultrasound, the Cryo and Focal Laser Ablation, provide good outcomes and become new promising tools for prostate cancer therapy. Physicians consider these methods worth using; the efficacy of some specific categories of patients being arguments for their use in the current protocols even though solid data regarding the improvement of global mortality rates are not yet published. The current article focuses on the newest systemic and local experimental treatment tools highlighting their benefits, especially for hormone-resistant prostate cancer.

260: High Intensity Focused Ultrasound Combined with Endocrine Therapy in Treating High or Intermediate Risk Prostate Cancer

2006 ◽  
Vol 175 (4S) ◽  
pp. 86-86
Author(s):  
Makoto Sumitomo ◽  
Junichi Asakuma ◽  
Yasumasa Hanawa ◽  
Kazuhiko Nagakura ◽  
Masamichi Hayakawa
Keyword(s):  
Prostate Cancer ◽  
Endocrine Therapy ◽  
High Intensity ◽  
Focused Ultrasound ◽  
High Intensity Focused Ultrasound ◽  
Intermediate Risk ◽  
Risk Prostate Cancer
Sign in / Sign up

Export Citation Format

Share Document